Literature DB >> 24768065

The Mertk receptor tyrosine kinase promotes T-B interaction stimulated by IgD B-cell receptor cross-linking.

Wen-Hai Shao1, Yuxuan Zhen1, Fred D Finkelman2, Philip L Cohen3.   

Abstract

The Mertk receptor tyrosine kinase facilitates macrophage and DC apoptotic-cell clearance and regulates immune tolerance. Mertk may also contribute to B-cell activation, because Mertk-KO mice fail to develop autoantibodies when allo-activated by T cells. We investigated this possibility with a well-characterized model in which injection of mice with goat anti-IgD antibody causes membrane IgD cross-linking that induces T-independent B cell activation and antigen presentation to T cells. Goat anti-mouse IgD antibody-injected C57BL/6 Mertk-KO mice had normal initial B cell activation and proliferation, but significantly lower T cell activation and proliferation, as well as lower IgE and IgG anti-goat IgG responses, as compared to C57BL/6 WT controls. B cell antigen processing, analyzed by evaluating B cell fluorescence following injection of monoclonal anti-IgD antibody labeled with biotin or FITC, was comparable between Mertk-KO mice and WT mice. IgD Ab primed B cells from Mertk-KO mice exhibited significantly lower ability in activating memory T cells isolated from WT mice injected with the same antigen 10 days before. These observations suggest that Mertk expression is required for optimal B-cell antigen presentation, which is, in turn, required in this model for optimal T cell activation and subsequent T cell-dependent B cell differentiation.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Ag presentation; IgD cross-linking; Mertk

Mesh:

Substances:

Year:  2014        PMID: 24768065      PMCID: PMC4162827          DOI: 10.1016/j.jaut.2014.03.004

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  26 in total

1.  Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family.

Authors:  Q Lu; G Lemke
Journal:  Science       Date:  2001-07-13       Impact factor: 47.728

2.  IL-4 suppression of in vivo T cell activation and antibody production.

Authors:  S C Morris; W C Gause; F D Finkelman
Journal:  J Immunol       Date:  2000-02-15       Impact factor: 5.422

3.  Polyclonal activation of the murine immune system by an antibody to IgD. I. Increase in cell size and DNA synthesis.

Authors:  F D Finkelman; I Scher; J J Mond; J T Kung; E S Metcalf
Journal:  J Immunol       Date:  1982-08       Impact factor: 5.422

4.  Polyclonal activation of the murine immune system by an antibody to IgD. II. Generation of polyclonal antibody production and cells with surface IgG.

Authors:  F D Finkelman; I Scher; J J Mond; S Kessler; J T Kung; E S Metcalf
Journal:  J Immunol       Date:  1982-08       Impact factor: 5.422

Review 5.  Lymphokine control of in vivo immunoglobulin isotype selection.

Authors:  F D Finkelman; J Holmes; I M Katona; J F Urban; M P Beckmann; L S Park; K A Schooley; R L Coffman; T R Mosmann; W E Paul
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

6.  Phagocytosis and clearance of apoptotic cells is mediated by MER.

Authors:  R S Scott; E J McMahon; S M Pop; E A Reap; R Caricchio; P L Cohen; H S Earp; G K Matsushima
Journal:  Nature       Date:  2001-05-10       Impact factor: 49.962

7.  Polyclonal activation of the murine immune system by an antibody to IgD. VI. Influence of doses of goat anti-mouse delta chain and normal goat IgG on B lymphocyte proliferation and differentiation.

Authors:  F D Finkelman; J Smith; N Villacreses; E S Metcalf
Journal:  Eur J Immunol       Date:  1985-04       Impact factor: 5.532

8.  Polyclonal activation of the murine immune system by an antibody to IgD. VIII. Stimulation of IgD secretion.

Authors:  J D Mountz; J Smith; C M Snapper; J F Mushinski; F D Finkelman
Journal:  J Immunol       Date:  1987-10-01       Impact factor: 5.422

9.  Polyclonal activation of the murine immune system by a goat antibody to mouse IgD. IX. Induction of a polyclonal IgE response.

Authors:  F D Finkelman; C M Snapper; J D Mountz; I M Katona
Journal:  J Immunol       Date:  1987-05-01       Impact factor: 5.422

10.  Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase.

Authors:  Philip L Cohen; Roberto Caricchio; Valsamma Abraham; Todd D Camenisch; J Charles Jennette; Robert A S Roubey; H Shelton Earp; Glenn Matsushima; Elizabeth A Reap
Journal:  J Exp Med       Date:  2002-07-01       Impact factor: 14.307

View more
  2 in total

1.  Ezh2-mediated epigenetic modification is required for allogeneic T cell-induced lupus disease.

Authors:  Yuxuan Zhen; Roger D Smith; Fred D Finkelman; Wen-Hai Shao
Journal:  Arthritis Res Ther       Date:  2020-06-05       Impact factor: 5.156

Review 2.  TAM-ing T cells in the tumor microenvironment: implications for TAM receptor targeting.

Authors:  Marlies J W Peeters; Anne Rahbech; Per Thor Straten
Journal:  Cancer Immunol Immunother       Date:  2019-10-29       Impact factor: 6.968

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.